Cargando…
A murine malaria protocol for characterizing transmission blocking benefits of antimalarial drug combinations
BACKGROUND: Current efforts towards malaria elimination include the discovery of new transmission blocking (TB) drugs and identification of compounds suitable to replace primaquine, recommended as transmission blocking post treatment after artemisinin combination therapy (ACT). High through put scre...
Autores principales: | Ebstie, Yehenew A., Guedoung, Alain R. Tenoh, Habluetzel, Annette |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dutch Malaria Foundation
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8415060/ https://www.ncbi.nlm.nih.gov/pubmed/34532220 |
Ejemplares similares
-
In vitro Multistage Malaria Transmission Blocking Activity of Selected Malaria Box Compounds
por: Malebo, Hamisi M, et al.
Publicado: (2020) -
Efficacy of Chloroquine for the Treatment of Vivax malaria in Northwest Ethiopia
por: Beyene, Habtamu Bedimo, et al.
Publicado: (2016) -
Tafenoquine and its potential in the treatment and relapse prevention of Plasmodium vivax malaria: the evidence to date
por: Ebstie, Yehenew A, et al.
Publicado: (2016) -
Transmission-blocking activity of antimalarials for Plasmodium vivax malaria in Anopheles darlingi
por: Andrade, Alice O., et al.
Publicado: (2023) -
Assessment of therapeutic efficacy and safety of artemether-lumefantrine (Coartem®) in the treatment of uncomplicated Plasmodium falciparum malaria patients in Bahir Dar district, Northwest Ethiopia: an observational cohort study
por: Ebstie, Yehenew A., et al.
Publicado: (2015)